LumiraDx Limited Warrant
LMDXW
LMDXW was delisted on the 8th of January, 2024.
20 hedge funds and large institutions have $37.1M invested in LumiraDx Limited Warrant in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less funds holding
Funds holding: 24 → 20 (-4)
35% less capital invested
Capital invested by funds: $57.1M → $37.1M (-$20.1M)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICMH
Integrity Capital Management (HK)
Central,
Hong Kong
|
-$71.9K |
| 2 |
CH
CVS Health
Woonsocket,
Rhode Island
|
-$55.4K |
| 3 |
MFW
Meristem Family Wealth
Minnetonka,
Minnesota
|
-$49K |
| 4 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$26K |
| 5 |
CF
Cantor Fitzgerald
New York
|
-$17K |
LMDXW Hedge Fund Activity: Q1 2022 in Review
20 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in LumiraDx Limited Warrant (LMDXW) for Q1 2022, worth a combined $37.1M — down 35% from $57.1M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of LMDXW and 0 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $1.79K. The largest seller was Integrity Capital Management (HK), cutting an estimated $71.9K.
- 20 institutional investors held LumiraDx Limited Warrant (LMDXW) as of Q1 2022, down from 24 in Q4 2021.
- Funds reported $37.1M of LumiraDx Limited Warrant stock for Q1 2022, down 35% quarter-over-quarter.
- 0 funds opened new LumiraDx Limited Warrant positions in Q1 2022 and 4 closed out, a net change of -4 holders.
- The largest LumiraDx Limited Warrant buyer in Q1 2022 was UBS Group, an estimated $1.79K added.
- The largest LumiraDx Limited Warrant seller in Q1 2022 was Integrity Capital Management (HK), an estimated $71.9K sold.
Based on aggregated 13F filings for Q1 2022.